Patents by Inventor Robert A. Mateer

Robert A. Mateer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6929954
    Abstract: A method for separating and purifying the active hematinic species (AHS) present in iron-saccharidic compositions, including AHS such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function. The method separates the AHS from one or more excipients and, preferably, lyophilizes the separated AHS. Separation of the AHS permits its analytical quantification, further concentration, purification and/or lyophilization as well as preparation of new and useful products and pharmaceutical compositions.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: August 16, 2005
    Assignee: Chromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer
  • Publication number: 20040220141
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes including sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Application
    Filed: June 1, 2004
    Publication date: November 4, 2004
    Applicant: Chromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer
  • Publication number: 20040038930
    Abstract: A method for separating and purifying the active hematinic species (AHS) present in iron-saccharidic compositions, including AHS such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function. The method separates the AHS from one or more excipients and, preferably, lyophilizes the separated AHS. Separation of the AHS permits its analytical quantification, further concentration, purification and/or lyophilization as well as preparation of new and useful products and pharmaceutical compositions.
    Type: Application
    Filed: June 20, 2003
    Publication date: February 26, 2004
    Applicant: Chromaceutical Advanced Technologies,
    Inventors: Robert A. Beck, Robert A. Mateer
  • Publication number: 20030153086
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes comprising sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Application
    Filed: February 21, 2003
    Publication date: August 14, 2003
    Inventors: Robert A. Beck, Robert A. Mateer
  • Patent number: 6537820
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes including sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: March 25, 2003
    Assignee: Cromaceutical Advanced Technologies, Inc.
    Inventors: Robert A. Beck, Robert A. Mateer
  • Publication number: 20020076821
    Abstract: A method for separating and purifying the active hematinic species present in iron-saccharidic complexes comprising sodium ferric gluconate complex in sucrose, ferric hydroxide-sucrose complex and ferric saccharate complex and others of similar form and function, based on separation of the iron-saccharidic complex from one or more excipients and, preferably, lyophilization. Separation of the iron-saccharidic complex permits its analytical quantification; further concentration or purification as a new and useful product; preparation of redesigned formulations for new and useful pharmaceuticals; and/or lyophilization.
    Type: Application
    Filed: October 31, 2001
    Publication date: June 20, 2002
    Inventors: Robert A. Beck, Robert A. Mateer